This human breast cancer cell line contains a KRASG13D mutation [16], displays elevated YB-1 expression [36] and displays aggressive tumorigenic and metastatic activities when transplanted into highly immunodeficient female mice [11, 37]. Here, YBX1 is linked to breast carcinoma.